Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
Hong Kong
· Delayed Price · Currency is HKD 30.20
+0.58 (1.96%)
Mar 10, 2026, 1:14 PM HKT
HKG:1501 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 6,232 | 5,095 | 4,891 | 4,830 | 3,818 | 6,789 | Upgrade
|
| Market Cap Growth | 33.62% | 4.18% | 1.25% | 26.51% | -43.77% | 31.72% | Upgrade
|
| Enterprise Value | 6,395 | 4,791 | 4,547 | 4,206 | 2,982 | 5,633 | Upgrade
|
| Last Close Price | 29.62 | 28.95 | 28.29 | 28.15 | 22.01 | 38.75 | Upgrade
|
| PE Ratio | 24.81 | 26.47 | 29.23 | 32.83 | 21.76 | 47.11 | Upgrade
|
| Forward PE | - | 18.88 | 20.44 | 23.81 | 23.81 | 53.08 | Upgrade
|
| PS Ratio | 6.18 | 5.62 | 5.90 | 7.29 | 6.69 | 15.95 | Upgrade
|
| PB Ratio | 2.90 | 2.68 | 2.65 | 2.75 | 2.16 | 4.31 | Upgrade
|
| P/TBV Ratio | 4.96 | 2.98 | 2.92 | 2.84 | 2.24 | 4.40 | Upgrade
|
| P/FCF Ratio | 38.93 | 47.97 | 476.97 | - | - | 721.84 | Upgrade
|
| P/OCF Ratio | 23.37 | 21.23 | 24.92 | 23.68 | 42.75 | 59.73 | Upgrade
|
| PEG Ratio | - | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | Upgrade
|
| EV/Sales Ratio | 6.34 | 5.29 | 5.48 | 6.35 | 5.23 | 13.23 | Upgrade
|
| EV/EBITDA Ratio | 18.71 | 15.70 | 20.16 | 23.26 | 14.39 | 33.12 | Upgrade
|
| EV/EBIT Ratio | 25.26 | 21.24 | 25.48 | 28.77 | 16.79 | 37.84 | Upgrade
|
| EV/FCF Ratio | 39.95 | 45.11 | 443.50 | - | - | 598.89 | Upgrade
|
| Debt / Equity Ratio | 0.29 | 0.14 | 0.06 | 0.03 | 0.01 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 1.82 | 0.84 | 0.45 | 0.29 | 0.08 | 0.01 | Upgrade
|
| Debt / FCF Ratio | 3.90 | 2.44 | 10.18 | - | - | 0.22 | Upgrade
|
| Net Debt / Equity Ratio | 0.03 | -0.17 | -0.20 | -0.31 | -0.44 | -0.71 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.21 | -1.07 | -1.66 | -3.00 | -3.71 | -6.56 | Upgrade
|
| Net Debt / FCF Ratio | 0.44 | -3.09 | -36.49 | 7.64 | 3.06 | -118.67 | Upgrade
|
| Asset Turnover | 0.38 | 0.40 | 0.39 | 0.34 | 0.31 | 0.26 | Upgrade
|
| Inventory Turnover | 2.05 | 2.16 | 2.22 | 2.05 | 2.56 | 2.52 | Upgrade
|
| Quick Ratio | 0.86 | 1.54 | 1.77 | 2.51 | 4.70 | 10.94 | Upgrade
|
| Current Ratio | 1.25 | 2.05 | 2.29 | 3.35 | 5.60 | 11.87 | Upgrade
|
| Return on Equity (ROE) | 10.59% | 10.97% | 9.48% | 8.95% | 10.16% | 9.10% | Upgrade
|
| Return on Assets (ROA) | 5.99% | 6.18% | 5.25% | 4.69% | 5.94% | 5.76% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.92% | 13.41% | 11.74% | 12.71% | 21.77% | 37.67% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.60% | 11.60% | 9.50% | 8.10% | 9.90% | 9.40% | Upgrade
|
| Earnings Yield | 3.15% | 4.01% | 3.52% | 3.08% | 4.60% | 2.12% | Upgrade
|
| FCF Yield | 2.57% | 2.08% | 0.21% | -1.47% | -6.59% | 0.14% | Upgrade
|
| Dividend Yield | - | - | 1.05% | 0.96% | 1.45% | 0.87% | Upgrade
|
| Payout Ratio | - | 24.55% | 25.77% | 33.16% | 33.09% | 23.94% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | 0.11% | -1.10% | -1.32% | -0.48% | -31.04% | Upgrade
|
| Total Shareholder Return | -0.01% | 0.11% | -0.05% | -0.36% | 0.97% | -30.17% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.